/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

BIOVIE INC Share Price Today: Live Updates & Key Insights

BIOVIE INC share price today is $1.3, up -17.81%. The stock opened at $1.42 against the previous close of $1.46, with an intraday high of $1.4397 and low of $1.3299.

BIOVIE INC Share Price Chart

style
pb-0

BIOVIE INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

BIOVIE INC Share Price Performance

$1.3 -0.1781(-17.81%) BIVI at 23 Mar 2026 12:14 PM Biotechnology
Lowest Today 1.3299
Highest Today 1.4397
Today’s Open 1.42
Prev. Close 1.46
52 Week High 13.20
52 Week Low 1.06
Day’s Range: Low 1.3299 High 1.4397
52-Week Range: Low 1.06 High 13.20
1 day return -
1 Week return -8.65
1 month return +3.52
3 month return -3.64
6 month return -30.52
1 year return +12.82
3 year return -85.34
5 year return -93.98
10 year return -

BIOVIE INC Institutional Holdings

Diametric Capital, LP 4.91

Vanguard Group Inc 2.83

Prosperity Wealth Management Inc 1.90

Vanguard Total Stock Mkt Idx Inv 1.74

Springbok Capital Management, LLC 1.22

Philadelphia Trust Co 0.99

Geode Capital Management, LLC 0.73

Vanguard Institutional Extnd Mkt Idx Tr 0.59

Fidelity Extended Market Index 0.56

Morgan Stanley - Brokerage Accounts 0.40

Renaissance Technologies Corp 0.37

Two Sigma Investments LLC 0.28

Citadel Advisors Llc 0.24

FMR Inc 0.22

Squarepoint Ops LLC 0.19

NT Ext Equity Mkt Idx Fd - L 0.19

HPM Partners LLC 0.16

Jane Street Group LLC 0.14

Belfund SICAV Belinvest Equity A USD Acc 0.13

Fidelity Series Total Market Index 0.08

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.07

Spartan Total Market Index Pool G 0.06

UBS Group AG 0.04

Fidelity Total Market Index 0.03

Hanson Mcclain Inc 0.03

Northern Trust Extended Eq Market Idx 0.02

Atlantic Trust Group, LLC 0.01

Vanguard Instl Ttl Stck Mkt Idx Tr 0.01

PNC Financial Services Group Inc 0.01

Royal Bank of Canada 0.01

Tower Research Capital LLC 0.01

Fidelity Nasdaq Composite Index 0.00

Spartan Extended Market Index Pool F 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Vanguard U.S. Eq Idx £ Acc 0.00

BNYM Mellon SL Market Completion UC1 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

State St US Extended Mkt Indx NL Cl C 0.00

BIOVIE INC Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

BIOVIE INC Fundamentals

Market Cap 11.23 M

PB Ratio 0.5088

PE Ratio 0.0

Enterprise Value -10.42 M

Total Assets 21.56 M

Volume 168796

BIOVIE INC Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-229377 -0.2M, FY24:-229377 -0.2M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-17542120 -17.5M, FY24:-32120533 -32.1M, FY23:-50255815 -50.3M, FY22:-22797050 -22.8M, FY21:-130808659 -130.8M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:-57344 -0.1M, Q3/2025:-57344 -0.1M, Q2/2025:-57344 -0.1M, Q1/2025:-57344 -0.1M, Q4/2024:-57344 -0.1M

Quarterly Net worth Q4/2025:-6069475 -6.1M, Q3/2025:-5087557 -5.1M, Q2/2025:-3489141 -3.5M, Q1/2025:-2788418 -2.8M, Q4/2024:-7156953 -7.2M

About BIOVIE INC & investment objective

Company Information BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Mr. Cuong Viet Do M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

BIOVIE INC FAQs

What is the share price of BIOVIE INC today?

The current share price of BIOVIE INC is $1.3.

Can I buy BIOVIE INC shares in India?

Yes, Indian investors can buy BIOVIE INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy BIOVIE INC shares in India?

You can easily invest in BIOVIE INC shares from India by:

Can I buy fractional shares of BIOVIE INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BIOVIE INC?

BIOVIE INC has a market cap of $11.23 M.

In which sector does BIOVIE INC belong?

BIOVIE INC operates in the Biotechnology sector.

What documents are required to invest in BIOVIE INC stocks?

To invest, you typically need:

What is the PE and PB ratio of BIOVIE INC?

The PE ratio of BIOVIE INC is N/A and the PB ratio is 0.51.